Cargando…
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics
(1) Background: The oncology field has drastically changed with the advent of precision medicine, led by the discovery of druggable genes or immune targets assessed through next-generation sequencing. Biomarker-based treatments are increasingly emerging, and currently, six tissue-agnostic therapies...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144220/ https://www.ncbi.nlm.nih.gov/pubmed/37111371 http://dx.doi.org/10.3390/ph16040614 |